Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Preliminary report of the use...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
Show other versions (2)
Detalles Bibliográficos
Main Authors:
Druce, M
,
Chung, T
,
Grozinsky-Glasberg, S
,
Gross, D
,
Grossman, AB
Formato:
Journal article
Idioma:
English
Publicado:
2012
Existencias
Descripción
Other Versions (2)
Títulos similares
Staff View
Títulos similares
Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.
por: Druce, M, et al.
Publicado: (2012)
Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
por: Druce, M, et al.
Publicado: (2010)
The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
por: Grozinsky-Glasberg, S, et al.
Publicado: (2010)
The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
por: Grozinsky-Glasberg, S, et al.
Publicado: (2009)
IGF-1 influences Everolimus activity in medullary thyroid carcinoma
por: Erica eGentilin, et al.
Publicado: (2015-05-01)